Global spinal cord stimulation device market to grow at 5.7% CAGR — 3 observations

Written by Megan Wood | October 10, 2017 | Print  |

The global spinal cord stimulation devices market will grow at a 5.7 compound annual growth rate through 2021, according to an iHealthcareAnalyst report.

Here are three observations:


1. The market is set to hit $2.4 billion by 2021.


2. Development of new applications and technologies is spurring market growth as well as the introduction of customized treatments.


3. Key market players include Abbott Laboratories, Boston Scientific Corp., Medtronic, Nevro Corp., Saluda Medical and Stimwave Technologies.

Editor's Note: An earlier version of this article included Integer Holdings Corp., as a key market player. Integer is a contract manufacturer/medical device outsourcer. The company does not directly sell spinal cord stimulator devices to hospitals. We regret this error.

More articles on devices:
Stryker to launch Tritanium C Anterior Cervical Cage in Q4 2017: 5 insights
Implant reports 20% Q3 revenue growth: 5 things to know
DePuy Synthes, Stryker & more: 5 device company mergers, acquisitions & agreementsttps://

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months